Research guide

Best DST Brokers (2026): How to Assess a Broker's Process for Rejecting an Offering

By Sequoia ResearchPublished Read as Markdown

What Is This Article About?

This article explains how to research a broker's process for saying no to a Delaware statutory trust (DST) offering. It reads selected public process descriptions from Fortitude, Realized, and Kay Properties, then separates those claims from evidence of actual decisions. Original examples show how rejection counts, review stages, exceptions, and changed documents can affect your assessment. No private committee files or complete rejection histories were obtained, and this is not a ranking of those firms.

Table of Contents

Start With What a DST Offering Rejection Means

A broker's choice to exclude an offering can be useful evidence. First, find out what was decided. An offering may have failed a review, remained incomplete, closed before review ended, or fallen outside the firm's business. Those outcomes should not share one vague label.

Think of the question as a small investigation. You want to know what the firm examined, which standard applied, and who made the decision. Then ask what the answer tells you about the offering now. An earlier decision may cover another version, year, or business unit. It may have limited use for your current choice.

A Missing Listing Is Not a Rejection Record

Suppose a fictional firm, Alder Research Brokerage, lists eight offerings on its website. Another platform lists twelve. It would be a mistake to conclude that Alder rejected the other four. The lists may cover different dates, distribution agreements, minimums, or property types. Some offerings may not have been presented to Alder at all.

There is also a difference between an offering and its place on a website. A page can disappear after the equity is fully subscribed. Another page can remain visible as a historical example. Neither website event, alone, explains an investment committee's conclusion.

Use precise descriptions. Write that an offering was not found on the public page on a stated date. If the firm later confirms that it declined the offering, add the reason and scope of that response. Do not rewrite the earlier absence as proof of something you learned only later.

Ask Which Level of Decision Is Being Described

A firm might decline a whole property strategy, one sponsor, or one trust. It may also decline one proposed investment for one client. The consequences differ. A concern may apply to one loan. That does not make it a finding about every offering from the same sponsor.

For an original example, Alder declines Trust A because a required lease amendment is not available. It continues to examine Trust B from the same sponsor. That is a trust-level decision under the example's policy. Saying that Alder rejected the sponsor would broaden the conclusion beyond its basis.

The reverse can also happen. A firm may pause new work with a sponsor while it studies a common issue. In that case, treating every affected offering as an unrelated rejection can hide the shared reason. Preserve both the scope of the decision and the list of items it affects.

Read Public DST Broker Screening Claims Carefully

The following public pages were read on October 18, 2026. They are selected descriptions of process, not audited accounts of completed reviews. The pages do not provide a matched decision history that would support a comparative rejection rate.

Fortitude: A Stated Committee and Decline Process

Fortitude's due-diligence page describes analysts reviewing the sponsor, property, market, structure, and tax treatment before presenting findings to an investment committee. It says the firm declines a significant share of presented offerings for property, sponsor, financing, or market reasons. The page gives no exact percentage or measurement period for that claim. Its footer identifies Concorde Investment Services as the securities firm and says Fortitude is independent of it. These are the site's descriptions; they do not establish the records behind each rejection. Fortitude due-diligence page

Realized: A Stated Review Before Portfolio Inclusion

Realized's broker-dealer partner page names Realized Financial, Inc. as its broker-dealer and describes review of the sponsor, real estate, and investment structure. It then describes a committee review and says that only offerings passing both reviews enter its custom portfolios. This supports a stated approval sequence. The page does not supply the full set of submissions, rejected cases, or committee decisions needed to test how that sequence operated. Realized broker-dealer partner page

Kay Properties: A Stated Gate Before Marketplace Listing

Kay Properties' process article describes sponsor materials, outside data, and an internal report. The report covers repairs, assumptions, charges, and loan terms, among other matters. It says properties that fail the review do not appear on its platform. That is a public statement about a listing gate. This article has not inspected the underlying reports, tested the complete review population, or verified a rejection count. Other marketing comparisons on that page are outside this review. Kay Properties due-diligence process

These descriptions suggest useful follow-up topics. They do not show that one firm's judgment is better. A public explanation can be clear. The supporting records may still be private. A short public explanation can also coexist with substantial internal work. Mark what is available rather than assuming either result.

Identify Who Can Stop a DST Offering Review

The word review does not identify a decision maker. Ask who gathers and studies documents. Who can request more evidence? Who can approve or decline the product? A sales contact may explain the result without having authority to change it.

An original process map for Alder has four roles. A research analyst checks source records. A property specialist studies operating assumptions. A committee decides whether the product can enter the firm's menu. A client-facing professional considers an individual recommendation. This is an invented map, not a description of a named firm's actual staffing.

Find the Point Where an Unanswered Question Stops Progress

In the fictional map, the analyst finds a missing loan schedule. The committee cannot make its final decision until that schedule is reviewed. The missing information could change the decision. In that case, awaiting schedule is a clearer status than approved with paperwork pending.

Ask how the stop works in practice. Does the offering stay out of client presentations? Can the sales team describe it as under review? Who makes sure an old approval label is no longer used? These questions test whether the process has a clear consequence when evidence is missing.

Do not assume that more people always produce a better decision. Four signatures may reflect four separate checks. They could also show repeated use of one analysis. Ask what each person contributes and who resolves disagreement. A large committee is not itself proof that a difficult issue received careful attention.

Keep Firm Duties Separate From a Reader's Checklist

The Financial Industry Regulatory Authority (FINRA) explains in Notice 23-08 that covered members must reasonably investigate recommended private placements. Its discussion includes issuer claims, warning signs, outside reports, and the effect of an offering's timetable. It says identified warning signs must be addressed before recommendation and cautions against reliance only on issuer representations. The notice also distinguishes product-level work from duties toward the particular customer. This article's examples are research aids, not a compliance test or a substitute for those duties. FINRA Notice 23-08

When a contact says the home office approved an offering, ask what that approval covers. The answer may establish permission to offer the product through that firm. It does not tell you that the same investment belongs in your portfolio or that every later document change has been checked.

Define the Population Behind a Rejection Rate

A rejection rate needs both a count and a defined starting set. Without those, even an impressive percentage can be hard to interpret. Ask what enters the count, what leaves it, and which date determines each case's status.

Follow One Hypothetical Review Population

Imagine Alder receives material for 40 distinct offerings during a quarter. Ten fall outside its stated business scope. Six are withdrawn before a full review. Twenty-four reach a completed review, of which eight are declined and sixteen approved. Assume the categories do not overlap.

The completed-review rejection rate is eight divided by twenty-four, or 33.33%. The rejection share of all 40 submissions is 20%. Both calculations are correct under their labels. They answer different questions.

Now combine the ten out-of-scope items, six withdrawals, and eight declines. Twenty-four of forty submissions did not receive approval, or 60%. That is a nonapproval share. Calling it a 60% research rejection rate would imply that all twenty-four failed a completed review, which the example does not show.

Hypothetical status at quarter-end Offerings Included in completed reviews?
Outside business scope 10 No
Withdrawn before full review 6 No
Declined after completed review 8 Yes
Approved after completed review 16 Yes
Total distinct submissions 40 24 completed reviews

The table is an original illustration. No listed company supplied these figures. A real comparison also needs rules for pending cases. It must account for offerings presented before the period began.

Do Not Count Reasons as Separate Offerings

Suppose the eight declined offerings generate twelve recorded reasons: five financing concerns, four property concerns, and three sponsor concerns. The reason count is larger because an offering can have more than one issue. Twelve divided by twenty-four is 50%, but it is not the offering rejection rate.

Use a unique offering identifier and a separate list of reasons. This lets one case carry several concerns without becoming several rejected cases. It also helps show whether one recurring issue explains much of the total.

Be careful with resubmissions. If two declined offerings return with changed terms, there may be ten review events but still eight distinct originally declined offerings. Event counts can measure workload. Unique offering counts measure a different population. Choose the unit before comparing firms or periods.

Distinguish Failed Criteria From Missing Evidence

An offering can fail a clear condition, or the reviewer may lack enough information to decide. These findings differ. The first says what the record shows. The second says what the available record does not yet establish.

Make the Criterion Specific Enough to Apply

Consider a fictional policy that calls for at least $600,000 in unrestricted repair reserves for a particular plan. The source confirms $450,000 is available on the same basis. The shortfall is $150,000, or 25% of the stated requirement. That is a measurable failure against this invented policy.

Now change the facts. A budget shows $650,000 in reserves, but the reviewer cannot tell whether $200,000 is restricted to another purpose. The figure could include only $450,000 usable for the relevant repairs. The next step is to resolve the permitted use; the headline total does not answer it.

Neither $600,000 nor 25% is a universal DST rule. The example shows the form of a useful explanation: stated condition, matched evidence, and result. A real reserve judgment needs the property's needs, timing, contracts, and other facts. A neat number cannot replace that work.

Preserve Unknowns Without Softening Their Consequences

A firm may decide it cannot proceed. A key fact may still be unknown. That is a clear decision, even when it does not prove an adverse fact about the property. A missing inspection report is not proof of damage. It can still prevent the reviewer from reaching a supported conclusion.

Ask what would resolve the gap. A current report, a signed amendment, and an explanation from the party responsible for the record are different kinds of evidence. The response should address the missing fact, not merely repeat the sponsor's confidence in the investment.

In an original five-issue file, two conditions fail, two cannot be assessed, and one passes. There are four issues preventing completion under the example's rules. There are only two established failures. Labeling all four failures would overstate the evidence; treating the unknown two as passes would understate the unfinished work.

That distinction also helps you compare explanations. A candid unresolved issue can be more informative than an unsupported favorable label. The goal is to understand the basis for a decision, not to reward a reviewer for sounding certain.

Test How a Broker Handles Conflicting Evidence

Documents can disagree without either source being fraudulent. They may use different dates, definitions, or units. A useful process checks the difference. It then assesses what the difference means.

FINRA's 2026 oversight report was released in December 2025. It identifies failures involving unresolved warning signs, reliance only on prior issuer experience, and inadequate evidence of diligence. Its private-placement section also describes practices such as checking material claims and considering changes during an offering. These are general oversight findings and practices, not allegations about the firms sampled here. FINRA 2026 private-placement report

Reconcile the Basis Before Calling a Difference an Error

In a fictional property review, a brochure shows 96 occupied units out of 100. A later rent roll shows 92. Both may describe their own dates accurately. The difference is four occupied units and four percentage points. It is about a 4.17% decrease relative to the earlier occupied-unit count, not a four-percent relative decrease.

The analyst needs dates, units available for rent, and the meaning of occupied. A signed lease may not mean that rent has been collected. A unit taken out of service may change a denominator. Ask which source and definition the final analysis uses.

Then consider whether the change matters to the decision. If projected income depends on the earlier occupancy, the model may need revision. If the four units were already excluded from the forecast for a stated reason, the effect could differ. The source difference starts an inquiry; it does not finish it.

Require the Answer to Reach the Relevant Decision

Suppose a fictional analyst asks three questions about a loan. The sponsor supplies a newer agreement that answers two. A third question about a payment trigger remains open. Closing the entire inquiry because a new document arrived would skip the unresolved part.

A useful response identifies the clause, explains how it applies, and states whether the issue is resolved. The firm might understand a risk and choose to accept it. That differs from finding that the risk does not exist. Keep those outcomes separate in the explanation you receive.

Also ask whether a changed answer reaches the person who recommended the offering. A question may be resolved in a research file. That has little value to your decision if you are still being shown an old model. The final client explanation should match the evidence used for the current approval.

Ask What Happens When Terms Change

A review is tied to the materials and facts it examined. A later change can make part of the earlier work outdated. Ask which changes prompt a new review and how the firm records the result.

Connect Reopening to the Affected Assumption

Consider an original model with annual cash before interest of $900,000 and $10 million of interest-only debt. At 5%, annual interest is $500,000 and the simple remainder is $400,000. At 6%, interest is $600,000 and the remainder falls to $300,000. The rate rose one percentage point, but the simple remainder fell 25%.

This excludes principal payments, reserves, trust expenses, and other cash needs. It is not an actual distribution estimate. It shows why a small-looking term change can matter to an earlier decision. The affected model should be revised rather than preserving its old conclusion because the offering name stayed the same.

A different kind of change may have no financial effect. Correcting a mailing address is not the same as changing a borrower or a guarantee. A useful process separates key changes from clerical corrections. It explains why an issue did or did not require more work.

Keep the Old Decision and the New Decision Visible

In a fictional record, a committee approves an offering on October 2. A loan revision arrives on October 9. The firm pauses the offering and completes its new review on October 13. A current summary should show the latest status and the version it covers. The original approval remains part of the history.

From October 9 to October 13 is four elapsed days. That interval does not prove the review was thorough or rushed. The amount of changed material, the questions asked, and the work performed matter. A clock is useful context, not a substitute for the record.

Suppose five offerings were approved at the start of a period. Two are reopened after changes, and one of those is later approved again. Four are currently approved and one remains under review. Counting the old approvals plus the new one would produce six approval events, not six approved offerings.

This is especially important when a firm describes how often it says no. A pause followed by a supported approval is a sequence of decisions. It should not be presented as two distinct products or a permanent rejection unless that is what happened.

Review Exceptions and Conflicts Without Guessing

A stated policy is easier to assess when the firm can explain how exceptions work. An exception might concern a business preference, a review threshold, or a missing administrative item. Do not assume every policy can be waived, or that every exception has the same significance.

Ask What Changed the Decision

In an invented case, Alder prefers leases with at least seven years remaining at acquisition. One property has six years. The committee considers an exception because of other documented facts. That does not turn six years into seven. It means the firm accepted a departure from its own stated preference under the example.

A useful explanation identifies the policy, the departure, and the evidence considered. It also names the person or group authorized to decide. A vague statement that the property is special gives you little basis for assessing the reasoning.

Keep the distinction between policy and law clear. This example does not suggest that a committee can waive a legal requirement. If the firm cannot explain which kind of standard applies, request that clarification before relying on the exception story.

Examine Incentives Without Assuming Motive

Suppose a hypothetical firm receives $6,000 for one sale and $3,000 for another sale of the same investment amount. The $3,000 difference is relevant to a conflict discussion. It does not, by itself, prove why a reviewer approved or rejected either product.

Ask how the review handles financial interests, related companies, and repeat business. Does the person evaluating a concern have authority to stop the process? How are relationships explained to the client? What evidence supports the claim that the concern was resolved?

The Securities and Exchange Commission's (SEC) September 2026 private-placement bulletin encourages questions about a professional's compensation and business ties. It also explains limited disclosure, possible loss, and liquidity limits. A Form D filing is not SEC approval. A firm's own approval label should not be confused with regulator endorsement or a promise that the investment is safe. SEC private-placement bulletin

Do not use a conflict disclosure as a stand-alone verdict. Identify the actual relationship and how it bears on the decision. A source can establish a payment or business tie. It may not reveal the decision maker's reasoning. Preserve that boundary rather than filling it with suspicion or reassurance.

Separate Product Approval From Your Investment Fit

A product can meet a firm's general review standards and still be unsuitable for a particular need. Ask the professional to explain both decisions. The first concerns the offering. The second concerns your proposed use of it.

Use Your Constraints as a Separate Screen

For an original example, an investor has $250,000 available for a new allocation but needs to keep $70,000 for a stated future expense. That leaves $180,000 under this simplified cash plan. An offering with a $200,000 minimum exceeds that amount by $20,000, even if the firm has approved the product.

This is not a recommendation to invest the remaining $180,000. Other cash needs, risk, existing holdings, and tax questions could change the decision. The example shows that product approval cannot settle an investor-specific amount by itself.

The same applies to time. An investor may need reliable access to cash in three years. A modeled sale in year five does not meet that need simply because the forecast looks good. A forecast sale is also not a promise of liquidity in year five. Ask how uncertainty is handled in the recommendation.

Do Not Turn a Client-Specific Decline Into a Sponsor Claim

Imagine two clients review the same approved offering. One has a large exposure to the same region. The other has a different portfolio. Those facts may lead the professional to different conclusions. That does not imply the property changed between the two conversations.

In an original portfolio example, $180,000 already relates to one tenant group. A proposed $60,000 position would raise that exposure to $240,000. Against a fixed $800,000 portfolio measured on the same basis, the share moves from 22.5% to 30%. These percentages describe concentration, not a universal safe limit.

Ask whether the decline is based on a product concern, an investor concern, or both. That helps you understand what new information could change the conclusion. A different allocation amount might address one issue while leaving a problem with the underlying offering unresolved.

Assess the Process When Private Records Are Unavailable

You may be unable to inspect committee minutes or named rejected cases. That limit should change the strength of your conclusion. It need not end all useful research.

Request a Shareable Explanation of the Method

A firm may be able to provide a current policy summary, a blank issue form, or an example with sensitive details removed. Ask how the example was chosen. It might illustrate a normal process, an unusual dispute, or a simplified training case. Each has a different use.

A template shows the fields the firm intends to use. A completed example can show how those fields were filled for one case. A sample does not prove that the same care occurred in every case. Make the scope of your evidence visible in the notes.

You can also ask process questions without demanding private identities. Who can reopen an approval? What happens if a sponsor will not supply a requested record? How does the firm distinguish a failed criterion from a missing document? These questions focus on the mechanism rather than another investor's affairs.

Keep Access Limits Separate From Quality Findings

In an original ten-question research plan, six questions have supporting documents, two have oral explanations, and two remain unanswered. Written support covers 60% of the plan. Answers of either type cover 80%. Neither percentage is a rating of the broker's judgment or the quality of its approved investments.

An oral answer can be useful. It is harder to check later. Record who gave it, when, and the exact scope. If the firm supplies a written explanation later, connect it to the earlier question. Do not count the same answer twice just because it arrived in two forms.

A refusal to share a private file is not proof that no review occurred. At the same time, you should not mark the process independently verified when you have seen only its public description. A fair note might say that the firm describes a committee gate, while its operation across actual cases was not tested.

That language may feel less decisive than a star rating. It is more useful when the evidence is incomplete. It tells a reader both what was learned and how much confidence the available record can support.

Compare Screening Processes Without Inventing a Winner

A useful comparison begins with matched questions. It does not begin by awarding points for every appearance of words such as rigorous, selective, or independent. Those words need a defined process behind them.

Compare the Same Stage and Period

Suppose fictional Firm North declines four of ten completed reviews, while Firm South declines twelve of sixty. Their stated rates are 40% and 20%. North has the higher rate, but the figures do not establish better judgment. The starting submissions, strategies, review depth, and reasons may differ.

If North receives many unsuitable submissions while South screens them before formal intake, the rates reflect different starting populations. A comparison should explain that limit instead of calling the higher number more protective. Also check whether both figures use unique offerings and the same status date.

Rejecting more products is not an end in itself. A process should support sound decisions on the cases it receives. A low rate may result from a narrow intake with clear rules. A high rate may result from broad intake. Neither explanation can be assumed without evidence.

Write a Conclusion That Matches the Evidence

For a fictional comparison, one firm supplies a clear current method and a redacted example. Another supplies a general website statement but no further record. You can describe that difference in available evidence. You cannot conclude solely from it that the first firm will make better investments or that the second did no work.

Keep three judgments separate: clarity of the stated process, evidence that it operated in the reviewed cases, and the suitability of an actual recommendation. Each needs different information. Combining them into one score can hide the missing evidence.

Your final note should name a practical next step. It might be a request for the current approval scope, an explanation of a reopened issue, or confirmation that a material condition was satisfied. If the needed evidence remains unavailable, state that limit. A well-supported decision to keep investigating is more defensible than a ranking built from unmatched claims.

FAQ

Do the Best DST Brokers Reject the Most Offerings?

A high rejection rate does not establish better investment judgment. The rate depends on which offerings enter the population and what counts as a decline. Compare scope, dates, review stages, and reasons before interpreting the number. Even a well-defined rate is a process measure, not a forecast of returns.

Does an Offering Missing From a Broker's Website Mean It Failed Review?

No. It may be outside the firm's menu, fully subscribed, not presented, or still under review. Record the public absence as an observation on a date. A confirmed decline needs separate evidence of the decision and its scope.

Can I Ask for Examples of Rejected DST Offerings?

You can ask what the firm is able to share, including a policy summary or a case with private details removed. It may not provide named committee records. A limited sample can illustrate a process, but it does not verify the complete history or establish a comparative quality ranking.

Is a Missing Document the Same as a Failed Investment Test?

No. Missing evidence can prevent a supported decision without proving that an adverse fact exists. State what remains unknown and what record could resolve it. A firm may still decide not to proceed while that material uncertainty remains.

Can an Approved DST Be Reviewed Again?

A changed document or fact can affect an earlier conclusion. Ask how the firm handles updates, who can reopen a decision, and which version the current approval covers. An old approval should not silently stand in for review of materially different terms.

Does Broker Approval Mean the SEC Approved the Offering?

No. Internal product review and regulator approval are different concepts. The SEC does not approve offerings, and a Form D filing does not show SEC approval. Ask what the firm's label actually means and avoid treating it as a safety guarantee.

What Should I Ask Before Relying on a Broker's Screening Claim?

Ask what was reviewed, who could stop the process, which conditions applied, and what happened to unresolved issues. Then ask whether the current recommendation fits your own needs. Keep the firm's public description, actual supporting records, and your personal decision in separate parts of the review.

About Sequoia Research

Sequoia Research, LLC provides independent research on DSTs and other real estate investment offerings. This library explains how to read source records, check calculations, and organize investment research questions.

Sources